Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07426770

Comparison of Outpatient Rehabilitation Versus Self-training for the Treatment and Prevention of Postpartum Pelvic Floor Dysfunction

The main goal of this study to compare self-training postpartum and training with a specialist support (physiotherapist and physical medicine and rehabilitation doctor) effect on pelvic floor dysfunction prevention and treatment in postpartum period.

Hypothesis: The implementation of postpartum rehabilitation helps to alleviate existing symptoms of pelvic floor dysfunction and prevents pelvic floor dysfunction.

Study goals:

* To objectively evaluate changes in pelvic organ position and pelvic floor muscle function in postpartum period, before and after specialised rehabilitation program * To objectively evaluate pelvic floor symptoms and their influence on woman life quality * To compare data (changes in pelvic floor muscle coordination and strength, pelvic organ position and changes in life quality according to validated questionnaires)

Study participants will:

* Get an examination by obstetrician-gynaecologist, physical medicine and rehabilitation doctor and physiotherapist in 6 to 10 weeks postpartum period. * One group of participants will attend physiotherapy, biofeedback and electro stimulation procedures with a guidance of a specialist. * Other group of participants gets a recommendations and instructions of training and self-trains at home. To remind of training and help record training time "squeezy" app (an application designed for a mobile device) will be offered. * All groups of participants will be asked to fill life quality related questionnaires: (ICIQ-UI SF: International Consultation on Incontinence Questionnaire; P-QoL: Prolapse Quality-of-Life Questionnaire; PISQ-IR: Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire IUGA revised; FSFI: female sexual function index; MOS-SF36 Medical Outcomes Study Short Form-36).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Vilnius University: study centers: "Vilnius University Hospital " Santaros Clinic", "Vilniaus Gimdymo Namai"

Vilnius, Lithuania

Location status: Recruiting

Location contact

Karolina Eva Romeikiene, MD, PhD student

CONTACT

[email protected]

+37060406142

About this study

Objectives of the Biomedical Research:

  • To evaluate gynaecological examination data at 6-8 weeks postpartum, with additional assessment of: experienced pelvic floor dysfunction (PFD) symptoms and their impact on quality of life, pelvic organ positioning (Pelvic Organ Prolapse Quantification system - POP-Q), pelvic floor muscle (PFM) strength, fecal incontinence, diastasis recti abdominis (DRA), and pelvic/perineal ultrasound findings.
  • To evaluate patient examination data conducted by a physical medicine and rehabilitation physician and a physiotherapist at 6-10 weeks postpartum.
  • To assess changes in pelvic floor muscle activity, PFD symptoms, pelvic organ position, following the training procedures and at 6 and 12 months post-intervention.
  • To compare changes among two groups:

Supervised training (specialist-led);

Self-training at home (based on specialist recommendations);

  • To compare gynecological examination data, Oxford Scale scores, and St. Mark's scores among the study groups.
  • To compare changes in women's quality of life, sexual function, and clinical outcomes between the study groups based on validated questionnaires.
  • To develop recommendations for specialists and the public regarding the prevention of postpartum pelvic floor dysfunction based on the study findings.

Comprehensive Description of Evaluated Outcomes Primary and Secondary Study Endpoints

Primary Endpoints: Changes indicating the effect of applied rehabilitation measures on the reduction and prevention of pelvic dysfunction symptoms:

Change in PFM contraction force and strength according to the Modified Oxford Scale.

Change in POP-Q scores.

St. Mark's Score for fecal incontinence: evaluating the change in score over the course of the study.

Pelvic and perineal ultrasound data: assessing symmetrical PFM contraction, changes in vaginal hiatus width, and urethral mobility. Comparison of results between study groups.

Persistence of PFD symptoms as reported by patients.

Changes in Quality of Life (QoL) and clinical outcome questionnaires: * ICIQ-UI SF (International Consultation on Incontinence Questionnaire Short Form); P-QoL (Prolapse Quality-of-Life Questionnaire); PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA revised); FSFI (Female Sexual Function Index); MOS-SF36 (Medical Outcomes Study Short Form-36).

Changes in musculoskeletal functions: * Objective assessment of PFM state via contraction force and Pressure Biofeedback activity evaluation.

Assessment of diastasis recti abdominis using palpation and ultrasound.

Pain assessment (abdominal, perineal, pelvic, pubic symphysis, and lumbosacral) using the Visual Analogue Scale (VAS).

Evaluation of gait, balance, and coordination.

Core stability and transversus abdominis activity (using a stabilizer); static endurance tests for abdominal and back muscles.

Secondary Endpoints: Factors potentially influencing the effectiveness of the rehabilitation program:

Demographics and History: Mean age, BMI, parity (number of pregnancies/deliveries), neonatal weight, and head circumference.

Obstetric Factors: Mode of delivery, delivery-related factors (induction, gestational age, fetal presentation, delivery method: natural, ventouse, c-section).

Pathologies: Pregnancy-related diseases (nausea/vomiting, intrahepatic cholestasis, preeclampsia, gestational diabetes), infectious/inflammatory diseases during pregnancy.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • This pregnancy was singleton
  • No contraindications for physical activity
  • No connective tissue disorders (for example Ehlers-Danlos syndrome)
  • No neurological disorders to influence pelvic floor symptoms (for example clinically significant spinal disc herniation)

Exclusion criteria

  • Younger than 18 years
  • Twins or triplet pregnancy
  • Contraindications for physical activity
  • Connective tissue disorders
  • Neurological disorders

Treatment and study plan

Rehabilitation postpartum

Behavioral
  • 4 Times biofeedback training
  • 10 times physiotherapy with specialist
  • 10 times transcutaneal electrostimulation (TENS)

Other names: Physiotherapy, Biofeedback training, electrostimulation

Self-training

Behavioral
  • training at home after physiotherapist instructions
  • using an app to record training frequency, length

Other names: pelvic floor dysfunction app

Primary outcomes

  1. Improvement in pelvic floor dysfunction symptoms

    Time frame: Asked at the beginning (first postpartum visit, 6-8 weeks postpartum), after first set of training (6months), after second set of training (12 months)

    Self-reported improvement of symptoms (for example: pain, urinary incontinence, fecal incontinence, vaginal "laxity")

  2. Change in PFM contraction force and strength according to the Modified Oxford Scale

    Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning

    Individual change in Oxford scores (0-5), bigger number means stronger contraction.

  3. Change in POP-Q scale

    Time frame: Measured before starting the program, after first set of training (6 months from beginning) and after second set of training (12 months from beginning)

    changes in POP-Q scales (especially in gh - genital hiatus, pb - perineal body, measured by centimeters, bigger number in gh means wider genital hiatus -worse outcome; smaller number in pb means thin perineal body - worse outcome)

  4. Change in life quality questionnaires ICIQ-UI SF

    Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).

    Quality of Life (QoL) and clinical outcome questionnaires: * ICIQ-UI SF (International Consultation on Incontinence Questionnaire Short Form); scores 1-21, higher the number - worse outcome

  5. Better voluntary pelvic floor muscle control

    Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning

    observation (compensatory muscles: abdominal, thighs, glutes movements during the contraction)

  6. Objectively measured change in pelvic floor muscle strength

    Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning

    Contraction measured with Myomed biofeedback device (manometry kPha)

  7. Quality of Life (QoL) and clinical outcome questionnaires: P-QoL

    Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).

    P-QoL (Prolapse Quality-of-Life Questionnaire) measures the impact of pelvic organ prolapse (POP) on a patient's life across eight domains, with total scores ranging from 0 (best) to 100 (worst). High scores indicate poor quality of life, while lower scores (often <40 or <20) indicate higher QOL and improvement after intervention

  8. Quality of Life (QoL) and clinical outcome questionnaires: PISQ-IR

    Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)

    PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA revised) evaluates female sexual function (FSF) in women with pelvic floor disorders (PFD), using a 2.68 summary score cutoff for sexually active (SA) women to identify sexual dysfunction (values >2.68 indicate no dysfunction). The survey separates patients into SA and not sexually active (NSA) groups.

    SA Scale: Higher scores indicate better sexual function. A mean score (>2.68) suggests no dysfunction, with (90%) sensitivity and (73%) specificity.NSA Scale: Higher scores indicate a greater negative impact of pelvic floor disorders on sexual inactivity.

  9. Quality of Life (QoL) and clinical outcome questionnaires: FSFI (Female Sexual Function Index)

    Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)

    FSFI (Female Sexual Function Index) is a 19-item validated questionnaire assessing female sexual function over the past month, with total scores ranging from 2.0 to 36.0. A total score of ≤26.55 is the standard cutoff indicating a potential risk for Female Sexual Dysfunction (FSD). Higher scores indicate better, more robust sexual functioning

  10. Quality of Life (QoL) and clinical outcome questionnaires: MOS-SF36

    Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)

    MOS-SF36 (Medical Outcomes Study Short Form-36). s a 36-item, patient-reported survey measuring health-related quality of life across eight dimensions. Scores range from 0 to 100 for each subscale, with higher scores indicating better health functioning or fewer limitations. The survey evaluates physical, mental, and social health domains

Secondary outcomes

  1. Factors potentially influencing the effectiveness of the rehabilitation program: mean age

    Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum

    Age in years Advanced age is a risk factor for PFD

  2. Other participant and birth related factors which may have influence on pelvic floor: BMI

    Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum

    BMI (kg/m^2) Higher BMI is a risk factor for PFD

  3. Other participant and birth related factors which may have influence on pelvic floor: number of births

    Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum

    Number of births (after 22 gestational weeks) Higher number of births is a risk factor for PFD

  4. Other participant and birth related factors which may have influence on pelvic floor: mode of delivery

    Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum

    Mode of delivery: natural, vacuum, forceps, c - section Vacuum or forceps assisted delivery is related to higher PFD rates compared to c - section or natural

Study contacts

Contact information is provided by the study sponsor or research team.

Karolina Eva Romeikiene, Medical doctor, PHD student

CONTACT

[email protected]

+37060406142

Sponsors and collaborators

Lead sponsor

Vilnius University

Other

Collaborators

  • Vilnius Maternity Hospital
  • Vilnius University Hospital Santaros Klinikos

Registry information

Official study title

Prevention of Female Pelvic Floor Dysfunction Rehabilitation Postpartum.

Acronym: DDDPREV

Important dates

Study start
2024
Primary completion
2027
Study completion
2029
First posted
Feb 23, 2026
Registry last updated
Feb 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.